Regenerative Cell-based Therapies
A multi-disciplinary medical practice in the USA, has introduced a new way to treat chronic pain.
The practice has launched a Total Joint Rejuvenation Program, offering a proprietary regenerative cell therapy for the treatment of large joint osteoarthritis (shoulder, knee, hip and ankle) as well as degenerative spinal conditions.
It is anticipated that the therapy will be used to manage a variety of ailments, from a torn rotator cuff, to a former athlete’s lower back pain, or an active adult’s long-standing knee pain.
This advanced therapy treatment is a non-surgical outpatient procedure. An injectable regenerative tissue matrix derived from maternal placental tissue donated after a healthy, live birth, yielding healthy tissue rich in proteins, growth factors, hyaluronic acid, cytokines and other natural cells that heal soft tissue damage.
The treatment uses the building blocks for the cells in the body to regenerate tissue at the site of injection. Over the course of several weeks to months, the tissue is rebuilt, joints are healed and hopefully patients can go back to doing the activities they love, pain free. The procedure does not work in all cases. Patients suffering from any kind of joint, tendon or ligament pain in any area of their body may be considered candidates.
Placental tissue injections focus on harnessing the body’s natural regenerative power to transform damaged tissue into healthy tissue.
Tissues are sourced from screened donors after C-section births.
Such therapies have not been approved for widespread use in the UK at this time.